At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'
'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'
Janna Bakeer, a girl who attends Timpview High School in Provo City, Utah, tried to ride a bus home when the bus driver used the bus's intercom system and said, "Hey you with the blue hair thingie, get off the bus, you don't belong here," according Randall Spencer, the family's lawyer.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances